JP2012501968A5 - - Google Patents

Download PDF

Info

Publication number
JP2012501968A5
JP2012501968A5 JP2011524142A JP2011524142A JP2012501968A5 JP 2012501968 A5 JP2012501968 A5 JP 2012501968A5 JP 2011524142 A JP2011524142 A JP 2011524142A JP 2011524142 A JP2011524142 A JP 2011524142A JP 2012501968 A5 JP2012501968 A5 JP 2012501968A5
Authority
JP
Japan
Prior art keywords
cell
cells
cultured
anemia
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011524142A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012501968A (ja
JP5639058B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2009/001145 external-priority patent/WO2010025506A1/en
Publication of JP2012501968A publication Critical patent/JP2012501968A/ja
Publication of JP2012501968A5 publication Critical patent/JP2012501968A5/ja
Application granted granted Critical
Publication of JP5639058B2 publication Critical patent/JP5639058B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011524142A 2008-09-03 2009-09-03 造血前駆細胞の増殖 Active JP5639058B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19096708P 2008-09-03 2008-09-03
US61/190,967 2008-09-03
PCT/AU2009/001145 WO2010025506A1 (en) 2008-09-03 2009-09-03 Expansion of haemopoietic precursors

Publications (3)

Publication Number Publication Date
JP2012501968A JP2012501968A (ja) 2012-01-26
JP2012501968A5 true JP2012501968A5 (https=) 2012-06-28
JP5639058B2 JP5639058B2 (ja) 2014-12-10

Family

ID=41796639

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011524142A Active JP5639058B2 (ja) 2008-09-03 2009-09-03 造血前駆細胞の増殖

Country Status (9)

Country Link
US (2) US8828375B2 (https=)
EP (1) EP2324109B1 (https=)
JP (1) JP5639058B2 (https=)
KR (1) KR101708067B1 (https=)
CN (1) CN102144028B (https=)
AU (3) AU2009290134B2 (https=)
CA (1) CA2735800C (https=)
SG (1) SG193888A1 (https=)
WO (1) WO2010025506A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102651433B1 (ko) 2006-04-14 2024-03-25 아스텔라스 인스티튜트 포 리제너러티브 메디슨 혈관 콜로니 형성 세포
JP6041456B2 (ja) * 2006-07-12 2016-12-07 メゾブラスト,インコーポレーテッド 過剰新生血管形成の治療
CA2735800C (en) * 2008-09-03 2018-05-01 Angioblast Systems, Inc. Expansion of haemopoietic precursors
CA2803641A1 (en) 2010-07-02 2012-01-05 Mesoblast, Inc. Treatment of t-cell mediated immune disorders
WO2012162754A1 (en) * 2011-06-03 2012-12-06 Mesoblast, Inc Methods of treating or preventing neurological diseases
KR101786862B1 (ko) 2011-07-04 2017-10-18 메소블라스트, 아이엔씨. 류마티즘성 질환을 치료 또는 예방하는 방법
US8961956B2 (en) 2011-11-30 2015-02-24 Ocata Therapeutics, Inc. Mesenchymal stromal cells and uses related thereto
KR102246369B1 (ko) 2011-11-30 2021-04-29 아스텔라스 인스티튜트 포 리제너러티브 메디슨 중간엽 간질 세포 및 이에 관련된 용도
US9745551B2 (en) 2012-07-12 2017-08-29 Imstem Biotechnology, Inc. Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
CN103816183A (zh) * 2012-11-16 2014-05-28 臻景生物技术(上海)有限公司 间质血管层细胞和间充质祖细胞在预防或治疗骨性关节炎中的应用
CN115919901A (zh) * 2012-12-12 2023-04-07 麦瑟布莱斯特公司 治疗或预防呼吸病症的方法
CA3177929A1 (en) 2012-12-21 2014-06-26 Astellas Institute For Regenerative Medicine Methods for production of platelets from pluripotent stem cells and compositions thereof
EP3130668B1 (en) * 2014-04-07 2019-07-17 IUCF-HYU (Industry-University Cooperation Foundation Hanyang University) In-vitro expansion of erythroid cells
KR101980169B1 (ko) * 2016-04-06 2019-05-21 가톨릭대학교 산학협력단 중간엽 기질세포-기반 세포 치료에서의 이질적인 니치 활성
JP6963555B2 (ja) * 2016-09-02 2021-11-10 タカラバイオ株式会社 多能性幹細胞からミクログリアを得る方法
AU2020301413A1 (en) * 2019-06-24 2022-02-10 Children's Hospital Los Angeles BCL11B overexpression to enhance human thymopoiesis T cell function
CN115361960A (zh) * 2020-02-19 2022-11-18 迈索布拉斯特国际有限公司 用于治疗慢性移植物抗宿主病的方法
CN113750220B (zh) * 2020-06-02 2023-11-03 南京大学 间充质干细胞联合tpo及其类似物在治疗慢性髓性白血病中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ147799A0 (en) 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
AR051573A1 (es) * 2004-09-22 2007-01-24 Sds Digger Tools Pty Ltd Diseno de piston para martillo de fondo
CA2866468C (en) * 2004-09-24 2019-09-03 Mesoblast, Inc. Generating multipotential expanded mesenchymal precursor cell progeny (memp) from mesenchymal progenitor cells (mpc) and stimulation factor
WO2006113881A2 (en) * 2005-04-19 2006-10-26 The Johns Hopkins University Method of using stroma cells from cord blood to expand and engraft nucleated cells from cord blood
AU2006252363A1 (en) * 2005-06-02 2006-12-07 Stemcyte, Inc. Plasma-depleted, non-red blood cell-depleted cord blood compositions and methods of use
JP2007202506A (ja) * 2006-02-03 2007-08-16 Toshiba Ceramics Co Ltd ヒト造血幹細胞または造血前駆細胞の培養方法
CA2735800C (en) * 2008-09-03 2018-05-01 Angioblast Systems, Inc. Expansion of haemopoietic precursors

Similar Documents

Publication Publication Date Title
JP2012501968A5 (https=)
Karsunky et al. Flk2+ common lymphoid progenitors possess equivalent differentiation potential for the B and T lineages
Miao et al. Hematopoietic stem cell niches and signals controlling immune cell development and maintenance of immunological memory
Mishima et al. Effective ex vivo expansion of hematopoietic stem cells using osteoblast‐differentiated mesenchymal stem cells is CXCL12 dependent
Sitnicka et al. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool
Schuettpelz et al. Regulation of hematopoietic stem cell activity by inflammation
Karsunky et al. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo
Hanash et al. Donor CD4+ CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation
ES2856825T3 (es) Generación de células NK y progenitores de células NK
JP5639058B2 (ja) 造血前駆細胞の増殖
Caux et al. Sequential loss of CD34 and class II MHC antigens on purified cord blood hematopoietic progenitors cultured with IL-3: characterization of CD34-, HLA-DR+ cells
JP2005511084A5 (https=)
JP2008517948A5 (https=)
Xu et al. Optimizing allogeneic grafts in hematopoietic stem cell transplantation
Aljagthmi et al. Hematopoietic stem cells: Understanding the mechanisms to unleash the therapeutic potential of hematopoietic stem cell transplantation
Müller-Newen et al. Development of platelets during steady state and inflammation
WO2005046570A2 (en) Human stem cell materials and methods
US20140205582A1 (en) Megakaryocyte progenitor cells for production of platelets
Bock Assay systems for hematopoietic stem and progenitor cells
US9187728B2 (en) Method for producing hematopoietic stem cells
Hwang et al. Nonmarrow hematopoiesis occurs in a hyaluronic-acid-rich node and duct system in mice
Adigbli et al. Development of LT-HSC-reconstituted non-irradiated NBSGW mice for the study of human hematopoiesis in vivo
Reyes et al. Granulocyte colony-stimulating factor (G-CSF) transiently suppresses mitogen-stimulated T-cell proliferative response
Prabahran et al. Mature megakaryocytes acquire immune characteristics in a mouse model of aplastic anemia
JP7477520B2 (ja) 幹細胞療法